好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The Impact of Neurohospitalist Service on In-Patient Outcomes: An Academic Medical Center Experience
Neurologic 好色先生
P04 - (-)
249
BACKGROUND: At the University of Kansas Medical Center, neurologists have acted as consultants to various hospital services to help manage patients admitted with neurological disorders. Recently, the neurohospitalist specialty was created in response to increasing pressures from government and private healthcare agencies on hospitals to maximize the efficiency of inpatient neurological management. The neurohospitalist model is hypothesized to be more efficient than the consultant model, based on generalization from the internal medicine hospitalist service experiences. There is very little literature to support this notion. We sought to study the impact of neurohospitalist service on inpatient neurology outcomes at a tertiary academic medical center.
DESIGN/METHODS: This is a retrospective cohort study of patients admitted to the KUMC neurology service 2 years before and after implementing the neurohospitalist on July 1st, 2010. The outcome variables include duration of hospitalization for different neurological conditions, cost, inpatient mortality, 30-day readmission rate, and 3-month mortality. Results were adjusted for age, gender, and diagnosis.
RESULTS: The most common diagnoses treated in both periods were seizures, demyelinating disease, cerebrovascular disease, CNS infection, neuromuscular disease. There was no difference in the mean length of stay between two periods (5.4 vs 5.3 days; p =0.83).
CONCLUSIONS: The introduction of a neurohospitalist service at a tertiary medical center did not coincide with a reduction in length of stay.
Authors/Disclosures
Hassanain Toma, MD (Royal Columbian Hospital)
PRESENTER 		No disclosure on file
Manoj Mittal, MD (Sutter Medical Center, Sacramento) Dr. Mittal has nothing to disclose.
Gary S. Gronseth, MD, FAAN (University of Kansas) Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain & Life. Dr. Gronseth has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as a Member/EBM consultant Guideline Development Subcommittee with AAN.
Richard M. Dubinsky, MD, MPH, FAAN (University of Kansas Medical Center) Dr. Dubinsky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie Pharmaceuticals. An immediate family member of Dr. Dubinsky has stock in Abbvie and Abbott Labs. The institution of Dr. Dubinsky has received research support from CHDI. The institution of Dr. Dubinsky has received research support from Prilenia. The institution of Dr. Dubinsky has received research support from Sage Pharmaceuticals. The institution of Dr. Dubinsky has received research support from NIH/NINDS. Dr. Dubinsky has a non-compensated relationship as a Member, independent data safety monitoring board with Roche that is relevant to AAN interests or activities.
No disclosure on file